Robust Data Integration Method for Classification of Biomedical Data | JoVE Visualize

Area of Science:

Oncology
Bioinformatics
Data Science

Background:

Accurate cancer patient classification is crucial for effective treatment and prognosis.
Integrating diverse data types (clinical and molecular) offers potential for improved predictive models.
Current data integration strategies have limitations in maximizing predictive power.

Purpose of the Study:

To develop and evaluate a novel hybrid protocol for integrating clinical and molecular data for cancer patient classification.
To assess the performance of this hybrid approach compared to existing early and late integration methods.
To demonstrate the utility of synthetic variables derived from molecular data in enhancing predictive models.

Main Methods:

A hybrid data integration strategy combining early and late approaches was proposed.
Informative clinical features were augmented with classification results from molecular datasets, creating synthetic variables.
The protocol was applied to METABRIC breast cancer and TCGA urothelial bladder carcinoma datasets, utilizing gene expression, copy number aberrations, RNA-Seq, methylation, and protein array data.
Performance was evaluated using repeated cross-validation and compared against early integration and late integration via super learning.

Main Results:

The hybrid method achieved comparable performance to the best super learning variants.
The approach facilitated sensitivity analysis and recursive feature elimination, resulting in compact predictive models.
For breast cancer, the final model included eight clinical variables and two synthetic features.
For urothelial bladder carcinoma, a highly accurate model was built using only two clinical features and one synthetic variable.

Conclusions:

The inclusion of synthetic variables derived from RNA expression and copy number alterations significantly improves prognostic test quality.
The proposed hybrid data integration protocol offers a robust and efficient method for cancer patient classification.
This approach holds promise for broader adoption in clinical practice for enhanced cancer diagnostics and prognostics.